{"name":"Open Innovation Partners, Inc.","slug":"open-innovation-partners-inc","ticker":"","exchange":"","domain":"","description":"Open Innovation Partners, Inc. is a biotechnology company focused on developing innovative therapies. The company has a single discontinued drug candidate, TR1801-ADC, and limited public financial information.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxPbnFSNFVkemFOcWVQSjlxcWpraDllVzZmckJON2UzMVRMX2gxUDdFa01TRWl4TTBRRDFGMmFmblk2aG54VWNYM2d1dkdyNnBTV2VGTDNHWVAwbGcwMkR4ZkFOTmhscjQ1VzRLSXB1Z29Vb3ZWSURVUS03X2xhTlVLYWhMdzh3VmE5?oc=5","date":"2026-03-10","type":"pipeline","source":"조선일보","summary":"Samsung Biologics, Eli Lilly Establish Domestic LGL Base - 조선일보","headline":"Samsung Biologics, Eli Lilly Establish Domestic LGL Base - 조선일보","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiS0FVX3lxTE9uRk1FU21qNmhiMkZQa21lSENMVnF5UW4wR1pLc3ByRGJObFRVSXA4NExYbG9FQU1VUlBwZnFBMnpZSFBPU2lxWEZmUQ?oc=5","date":"2026-03-10","type":"pipeline","source":"매일경제","summary":"Samsung Biologics will join hands with U.S. pharmaceutical company Eli Lilly to establish a Korean b.. - 매일경제","headline":"Samsung Biologics will join hands with U.S. pharmaceutical company Eli Lilly to establish a Korean b.. - 매일경제","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiV0FVX3lxTE50aWY2MGVKQ210ZkQ1NXlPSm0zanFMWFNDNVV2Y2RLVUZydXVBcVdsQ3Z3UWxkMVZVOVVBZ25vZ2NkODJRRXVIVmZyVzV6YjdyQTNWT05fZw?oc=5","date":"2026-02-09","type":"pipeline","source":"The Korea Herald","summary":"Two biotech startups selected for Seoul-AstraZeneca joint program - The Korea Herald","headline":"Two biotech startups selected for Seoul-AstraZeneca joint program","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTFBSZkNkQXBHQTlyNHZtRDZ2ZjJET3V4U0pCMTFLLVl2YWRwMzdHY2g2NmozYndDanNSYkJFNGtLZmhCck45OFVjRTZHb2lfOTdKLVAtR2lLd2h3R1V1cDFN?oc=5","date":"2025-12-22","type":"pipeline","source":"asahi-kasei.com","summary":"Asahi Kasei Pharma to Relocate Global R&D Hub to Shonan iPark | 2025 | News - asahi-kasei.com","headline":"Asahi Kasei Pharma to Relocate Global R&D Hub to Shonan iPark | 2025 | News - asahi","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizwFBVV95cUxQVWEwUEFKdGdXaUcwQUlfdXhSZmNramRJU2xnQXFyNVgwRkROTUd3b3VRclJJcEpmc05pQXdrVEphbnhfMDcyVXh1amN4ems3RlNBSGF3TGpTbHlFSmdLdVdoaFRSOG5IMmlPMF85YVFaUnRvd2Y5VWc0eTFELV9iLUI1OUhjbkpiemFrbkN0YzJuakR2LXd1dmdBVnJucmF6ZWhWQmJxOWhwN1FCdGlFcHpHdjFqVDd6QzZVaXNXWXprTnVTUEZDV0ZDT3VwR1k?oc=5","date":"2025-12-19","type":"deal","source":"BioSpace","summary":"Meiji Seika Pharma Partners With MBC BioLabs to Strengthen Global Innovation in Drug Discovery - BioSpace","headline":"Meiji Seika Pharma Partners With MBC BioLabs to Strengthen Global Innovation in Drug Discovery","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxNNmZIOVF4Y2d0dTBEbGhLWHlHTF9FOUNKNjZLQ1laWVphc3lVdExBbU1MQnBmSUpFZmtKallRdmRhLTJfY29ka3dlQW9hQ045dUhYU09PZUtzc1B4SFlFc1paRUF2Y2NPQU5ISzZ2Y3BPS3RkRmptMk40OWFQTDNnRnBvcGtRX04x?oc=5","date":"2025-12-03","type":"pipeline","source":"조선일보","summary":"BMS Executive: AI to Reshape Pharmaceutical, Biotech Industries - 조선일보","headline":"BMS Executive: AI to Reshape Pharmaceutical, Biotech Industries - 조선일보","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiggFBVV95cUxOanRRaXM2TkxObmtBTHZRdXJLcjNhcU5OS2JwVG1nQTNSVktpaG10akFpUFRmSTdUYUlPTDRObkVNeDA5cmItS0JTdmM4X1Z5Q1JoZ1ZISTNOV01BRmQwYjhZOWYzS3dSa2hHQzJVLXQwRjZ5R1N0ODNkdm43R3RlaGJR?oc=5","date":"2025-07-30","type":"pipeline","source":"bain.com","summary":"Empowering Biotech Innovation in Asia-Pacific - bain.com","headline":"Empowering Biotech Innovation in Asia-Pacific","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2wFBVV95cUxOQU1UMVRBUlRIaE15U0JBd0wtR0gyVEt0N3pOeXZhWnZCdVAyX2tYNXJfTnV3M015b3ZJQ3N4WnlvdF85Y3pjRjU5R1ctMUdyMEktYVRCSjdrejhzaXk4UThiN1JCYVFBVzhzWnZPYTZkNEJReUlOQjU0VHZQc3l1VDN3SDlwT096NlY3N1d0blJEblRmUXpQUTF2SVZrbEdGMXhQbkF3aTBBTWpJMkk2bXplX2YyM3dXcW9LanVnZTZYNzdWNWhsZ3lQUkZOZGlUeUUyVHNNdWRmWVE?oc=5","date":"2025-06-05","type":"deal","source":"Ophthalmology Times","summary":"Kiora Pharmaceuticals and Senju Pharmaceutical partner on KIO-301 for retinal disease treatment in Asia - Ophthalmology Times","headline":"Kiora Pharmaceuticals and Senju Pharmaceutical partner on KIO-301 for retinal disease treatment in Asia","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE81dXh2UG5idzNQdEktdHEwM2s0a0tmbnVJbU40dG0xYzJlZGx1QXdmOHM4a0x5OHRFTll4bXFQWEVYdDZtdjBBQWtxMGo0ellyNzBocTM5amdaOWtjeWZzaHZDS1AzcmVkRmt5LW1R0gFyQVVfeXFMUDBNVDJ4bktRbjVoUXYxLUxFQ3RKZ0dDbUdVb2pPMHp4M2RZSGZuNV9fUEJ3QXZTSU0xa01SU0dtQ1N4cDE4a1Z5NERXZEROTEpsdDNWRlZlRWNST29hMzdDTFZ2aldTNTBpbWFBeGw4Zld3?oc=5","date":"2025-05-09","type":"pipeline","source":"koreabiomed.com","summary":"[BIO KOREA 2025] MSD bets big on Korean biotech for open innovation - koreabiomed.com","headline":"[BIO KOREA 2025] MSD bets big on Korean biotech for open innovation","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxPNHQ0STgtdkpsVWFOMDZwSTdaeVRmYzRSYUdZQzlZRllxbEZ0dkdQUUFnNl9aTWN5dGRuTWZnR1B6VzFGdVF4R2Z2UkxQZDRjdV93a0taRXd5VURUU1p2SXFHMlNVUTdUNDd6S2pSclc2NTdLUXVET2FiOUNOaXo4d3lfSzRUclBTQzJvOFdpd0tCaVRmenNfSFlsTjhLNUot?oc=5","date":"2025-04-07","type":"deal","source":"Harvard Business Review","summary":"Building Effective Partnerships to Power Life Sciences Innovation - SPONSOR CONTENT FROM ASTELLAS - Harvard Business Review","headline":"Building Effective Partnerships to Power Life Sciences Innovation - SPONSOR CONTENT FROM ASTELLAS","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxQb0xJbFQ4OUNYNE5ZMW9GVXFUcjNIMDRhLWpyT2xPNHljQk1xOFRVd25Cc3FNdy1CU1J3b1haR2JwdUl3MnBYcnh3NkJRYjlMclJkYThXd0sxS2Y5cnY3YTlyYi0yVlhKMlRNcEtGNWRxZEhkSmZMUk5CRUJ2cHUxV041Sk1XWXpRMWU3R1k2Vks4U1U?oc=5","date":"2021-01-13","type":"pipeline","source":"Frontiers","summary":"Open Innovation in Medical and Pharmaceutical Research: A Literature Landscape Analysis - Frontiers","headline":"Open Innovation in Medical and Pharmaceutical Research: A Literature Landscape Analysis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwJBVV95cUxPaU5kT2NiQTZpYzlWV2FCQjRGUkh3QVpQODhHQ241OFBiZ2RiT1BuSHNIVjVhSTQyaXpBaFBsMFRjLWRIaWpiUTlTNnptbE5SVmNJWDdBay1CZ2xZWm1VMENQeHdzZkZ2SHVtWHZwWTRUMVVSUWN0N01tX2hFZjJFc1hoMFpkTHo3VG9KMHFIUFZ4Y21WdUZNWGJVandscHR5dGdOc0QxVXF6VkRWSVNDdE9jYUVIZGNQZzlZYVFQbTFTUnhDRUh1bFh1SEp4V0VQZHVyNGhIY2lqcUZ4YTJKdlJiTWtOUFE0dnlKcG1XVXNrUGxobHkzdmdiaUdjRWtiYlNGU000c29Ud3Q3cmZWLXNvQXE3UmNQY0RuSEZ1QkF2cjR2NW1fSXV3QWsyRXc?oc=5","date":"2020-06-30","type":"deal","source":"PR Newswire","summary":"Repurpose.AI and LEO Pharma A/S Announce an Open Innovation Partnership to Discover and Validate Drugs to Treat Inflammatory and Dermatology Indications - PR Newswire","headline":"Repurpose.AI and LEO Pharma A/S Announce an Open Innovation Partnership to Discover and Validate Drugs to Treat Inflamma","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}